Astra will buy EsoBiotec for up to £770m comprised of an initial £327m payment and another £443m in the future if it hits agreed milestones.

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...

Cytokinetics has a strong cash runway but faces risks from its Royalty Pharma deal. Read more on what's ahead for this ...

The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all ...

AstraZeneca makes a deal to buy another biotech company, this one with a price tag that could reach $1 billion.

The deals are expected to shorten manufacturing timelines for cell therapies and reduce administration times for oncology ...

The European stock markets were moving higher in Monday trading as The Stoxx Europe 600 rose 0.75%, Germany's DAX was up 0.61%, the FTSE 100 in London gained 0.58%, France's CAC 40 increased 0.50%, ...

Find insights on AstraZeneca, Incyte and more in the latest Market Talks from the health-care sector.

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £190.00. The ...

AstraZeneca has signed two deals worth $1.35 billion with Alteogen to develop subcutaneous versions of the British pharma’s ...

The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating ...

British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up ...